This in turn aids in the suppression of effector CD4+ and CD8+ T cell function, required for anti-tumor immune responses, and correspondingly induces suppressive regulatory T cells, which further contribute to the suppression of effective anti-tumor immune responses. The gene discussed is CD4; the disease is neoplasm.